The Ruby Study is a clinical trial of a possible treatment for adults with gout who still have flare-ups despite taking allopurinol.
The study will test how effective and safe a study drug called (dotinurad) may be in treating gout compared to allopurinol. Taking part in the study lasts about 18 months and includes 21 study visits (some by phone). All participants will also receive, at no cost, a prescription for colchicine or a nonsteroidal anti-inflammatory drug (NSAID) to prevent flares.
Are 18 to 75 years old Have been diagnosed with gout for at least 1 year Have had 2 or more flare-ups in the last 12 months Have taken the same dose of allopurinol for at least 3 months prior to joining the study